Mostrando 10 resultados de: 16
Filtros aplicados
Publisher
Journal of Clinical Rheumatology(5)
Clinical Rheumatology(4)
Autoimmunity Reviews(2)
Annals of the Rheumatic Diseases(1)
Antibodies(1)
Área temáticas
Enfermedades(11)
Medicina y salud(10)
Cirugía y especialidades médicas afines(1)
Fisiología humana(1)
Problemas sociales y servicios a grupos(1)
Área de conocimiento
Inmunología(4)
Medicina interna(3)
Salud pública(2)
Cuidado de la salud(1)
Farmacología(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(16)
ODS 10: Reducción de las desigualdades(11)
ODS 17: Alianzas para lograr los objetivos(11)
ODS 12: Producción y consumo responsables(2)
ODS 1: Fin de la pobreza(2)
Origen
scopus(16)
Correction to: PANLAR consensus statement on biosimilars (Clinical Rheumatology, (2019), 38, 5, (1485-1496), 10.1007/s10067-019-04496-3)
OtherAbstract: The two co-authors of the mentioned above article were incorrect. The correct are authors should havPalabras claves:Autores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Beltrán P.A., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Díaz-Coto J.F., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusCurrent trends for biosimilars in the Latin American market
ArticleAbstract: The number of approved biological medicines in the global pharmaceutical market has increased in recPalabras claves:Biologicals, biopharmaceuticals, Biosimilars, Latin AmericaAutores:Claudio M. Galarza-Maldonado, Dámaris P. Intriago-Baldeón, Diana C. Checa-Jaramilloz, Diana Castillo, Esteban Ortiz-Prado, Felipe Andrade, Jorge Eduardo Vásconez, Nathalia Rodríguez-Burneo, Ponce-Zea J.Fuentes:scopusInfections and the antiphospholipid syndrome
ReviewAbstract: Currently, the origin of autoimmune diseases is considered to be multifactorial. Genetic predispositPalabras claves:Anticardiolipin, Antiphospholipid, infection, ThrombosisAutores:Cervera R., Claudio M. Galarza-Maldonado, Escárcega R.O., García-Carrasco M., Mendoza-Pinto C.Fuentes:scopusManagement of patients with rheumatoid arthritis in latin america: A consensus position paper from pan-american league of associations of rheumatology and grupo latino americano de estudio de artritis reumatoide
ArticleAbstract: OBJECTIVE:: A consensus meeting of representatives of 18 Latin-American and Caribbean countries gathPalabras claves:diagnosis, Latin America, Rheumatoid Arthritis, TreatmentAutores:Acevedo-Vázquez E., Caballero-Uribe C.V., Cardiel M.H., Claudio M. Galarza-Maldonado, Espinosa-Morales R., Laurindo I.M., Levy R.A., Massardo L., Millán A., Nava A., Pineda-Villaseñor C., Pons-Estel B.A., Soriano E.R., Suárez-Almazor M.E.Fuentes:scopusPrimary antiphospholipid syndrome in Latin American mestizo patients: Clinical and immunologic characteristics and comparison with European patients
ArticleAbstract: A great variety of clinical and immunological features have been described in patients with the antiPalabras claves:Anticardiolipin antibodies, antiphospholipid antibodies, Lupus anticoagulant, Primary antiphospholipid syndromeAutores:Cervera R., Claudio M. Galarza-Maldonado, Escárcega R.O., García-Carrasco M., López-Colombo A., Mejía-Romero R., Mendoza-Pinto C., Salinas-Saldivar S., Santos P., Soto-Vega E.Fuentes:scopusPANLAR consensus statement on biosimilars
ArticleAbstract: Introduction: Biologics have improved the treatment of rheumatic diseases, resulting in better outcoPalabras claves:Biosimilars, consensus, PANLAR, Rheumatic diseasesAutores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Roa P.A.B., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Soto L.D., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusThe HELLP syndrome, antiphospholipid antibodies, and syndromes
OtherAbstract:Palabras claves:Autores:Asherson R., Claudio M. Galarza-Maldonado, Sanin-Blair J.Fuentes:scopusThe administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus
ReviewAbstract: Background: In Latin America, the medical attention directed to systemic autoimmune diseases competePalabras claves:Autores:Cardiel M.H., Cervera R., Claudio M. Galarza-Maldonado, Doukh N., Kourilovitch M.R., Molineros J.E., Soroka N.F., Yagur V.Y., Zurita L.Fuentes:scopusTherapeutic Guidelines for Latin American Lupus Patients: Methodology
ArticleAbstract:Palabras claves:Autores:Acevedo-Vásquez E.M., Alarcón G.S., Amigo Castañeda M.C., Barile-Fabris L.A., Bonfá E.S.D.D.O., Cardiel M.H., Catoggio L.J., Chacón-DÍaz R., Claudio M. Galarza-Maldonado, Duarte M., Espada G., García M.A., Iglesias Gamarra A.J., Izcovich A., Levy R.A., Massardo L., Molina Restrepo J.F., Neira O., Pons-Estel B.A., Sato E.I., Silva C.A., Soriano E.R., Vargas Peña A., Vásquez G.Fuentes:scopusNeutrophil extracellular traps, antiphospholipid antibodies and treatment
ReviewAbstract: Neutrophil extracellular traps (NETs) are a network of extracellular fibers, compounds of chromatin,Palabras claves:Antibodies, Antiphospholipid syndrome, Autophagy, NETosis, Neutrophil extracellular trapsAutores:Bravo-Barrera J., Claudio M. Galarza-Maldonado, Kourilovitch M.R.Fuentes:scopus